ASCEND BY NTHRYS
Research Abroad Products

Applied Immunology Project Topics

Browse all focused areas across all project categories under this field.

Showing 97–108 of 200 project topics
Antibody Sequence Analysis and IP Landscape Intelligence
Database and analytics SaaS platform providing real-time benchmarking of antibody sequences against patent landscapes, clinical pipelines, and competitive therapeutics. Protects R&D investments and supports licensing negotiations, generating recurring enterprise subscription revenue.
Antibody Discovery & Engineering Service Tools Click to view more details →
Automated Antibody Manufacturability Assessment and Optimization
AI-powered tool evaluating expression yields, aggregation risks, and purification complexity at candidate selection stage with predictive manufacturing cost models. Reduces development-to-manufacturing transition failures by 50% and shortens scale-up timelines by 6-12 months.
Antibody Discovery & Engineering Service Tools Click to view more details →
Antibody Fragment and Scaffold Discovery from Display Libraries
Integrated discovery service combining scFv, nanobody, and alternative scaffold formats sourced from proprietary phage and yeast display libraries with ultra-deep sequencing. Expands addressable market through non-traditional formats and creates premium service tier opportunities.
Antibody Discovery & Engineering Service Tools Click to view more details →
Real-Time Antibody Binding Kinetics Profiling Instrument Service
Software-controlled surface plasmon resonance or biolayer interferometry service providing on-demand kinetic characterization (Kd, kon, koff) of antibody candidates with turnkey data analysis. Generates recurring service revenue through subscription-based instrument access and data interpretation.
Antibody Discovery & Engineering Service Tools Click to view more details →
Multi-Parameter Flow Cytometry SaaS Platform for Patient Stratification
A cloud-based software platform integrates real-time flow cytometry data analysis with machine learning algorithms to automatically classify patient immune phenotypes for clinical trial enrollment. This enables sponsors to reduce patient screening time by 60% while improving cohort homogeneity, directly increasing trial success rates and reducing time-to-market.
Immune Profiling for Clinical Trial Stratification Click to view more details →
AI-Driven T-Cell Receptor Sequencing Analysis Tool for Immunotherapy Trials
A commercial bioinformatics tool processes TCR-seq data to identify clonal expansion patterns and predict responders to checkpoint inhibitor therapies before treatment initiation. This proprietary analytics service commands premium pricing while enabling CROs to offer differentiated patient selection services that reduce trial failure rates.
Immune Profiling for Clinical Trial Stratification Click to view more details →
Immune Checkpoint Biomarker Panel Testing Service for Sponsor Networks
A CLIA-certified laboratory service delivers standardized PD-L1, TIM-3, and LAG-3 expression profiling across distributed trial sites using proprietary immunoassay kits and harmonized quality controls. This recurring revenue model captures $500-$2000 per patient test while establishing the service provider as the de facto standard in oncology trial stratification.
Immune Profiling for Clinical Trial Stratification Click to view more details →
Cytokine Signature Profiling Platform for Autoimmune Disease Trial Matching
A multiplexed assay platform simultaneously measures 40+ inflammatory cytokines from patient samples and outputs immune subtype classifications via proprietary machine learning algorithms. The platform licensing model generates recurring revenue through assay kit sales while improving autoimmune trial enrollment success by 45% through precise patient phenotyping.
Immune Profiling for Clinical Trial Stratification Click to view more details →
Real-Time Immune Cell Frequency Dashboard for Distributed Trial Operations
A web-based operational analytics tool aggregates automated complete blood count and immune cell differential data from geographically dispersed trial sites into a unified stratification database. This SaaS solution enables sponsors to dynamically adjust enrollment criteria and identify eligible cohorts in real-time, reducing patient recruitment timelines by 8-12 weeks.
Immune Profiling for Clinical Trial Stratification Click to view more details →
HLA Genotyping and Immunogenicity Prediction Engine for Vaccine Development
A proprietary software engine combines rapid HLA typing results with structural immunology algorithms to predict patient-specific T-cell epitope responses before trial randomization. This precision screening tool reduces late-stage trial failures by 35% while commanding licensing fees from vaccine developers seeking competitive advantage in immunogenicity prediction.
Immune Profiling for Clinical Trial Stratification Click to view more details →
Microfluidic Single-Cell Immune Profiling Device for Biomarker Discovery
A proprietary handheld microfluidic device profiles immune cell function and signaling responses from minimal blood volumes, generating real-time data streams to cloud analytics platforms. This hardware-software combination establishes a recurring consumables revenue stream while enabling sponsors to discover novel stratification biomarkers that differentiate responders from non-responders.
Immune Profiling for Clinical Trial Stratification Click to view more details →
Lymphocyte Activation Assay Platform for Adaptive Immunity Assessment
A commercial assay platform measures antigen-specific lymphocyte proliferation and activation kinetics using proprietary stimulation and detection reagents with automated image analysis software. This end-to-end solution enables CROs to offer functional immune assessment services that command premium pricing while providing mechanistic insights that enhance trial design credibility.
Immune Profiling for Clinical Trial Stratification Click to view more details →